Latest filing published 17 Dec 2007 for PANACOS PHARMACEUTICALS, INC., €2,078.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -83.1%Entry 0.83 · Close at T+365 0.14
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Thomas Lategan: trading record in brief
This profile gathers the share dealings of Thomas Lategan in Panacos Pharmaceuticals, Inc. Over a trading history stretching from 2 November 2007 to 14 December 2007, the count stands at 3 filings.
Purchases make up the whole of the open-market record (2 purchases, €6,955). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 share grant.
The latest filing, published on 17 December 2007, reports an open-market purchase of €2,078 in Panacos Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Thomas Lategan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,530 shares@ US$0.85Common StockSEC:0001181431-07-075782:0Canonical exit: 13 Mar 2008 (T+90)
- 8,000 shares@ US$0.88Common StockSEC:0001181431-07-075782:1Canonical exit: 13 Mar 2008 (T+90)
- 35,000 shares0Common StockSEC:0001181431-07-066813:0
3 of 3 declarations
